Defined Benefit (Pension) · DOL Form 5500 · 2022
Takeda Pharmaceuticals North America, Inc Pension Plan
Data updated 2026-08-11
- $334M
- Total assets
- 591
- Participants
- 97th
- Percentile by assets
- $564,833
- Avg per participant
Official DOL plan name: Baxalta Incorporated and Subsidiaries Pension Plan · Sponsored by Takeda Pharmaceuticals North America, Inc · Pennsylvania · Manufacturing
$334M in assets, 591 participants
Takeda Pharmaceuticals North America, Inc's Baxalta Incorporated and Subsidiaries Pension Plan reported $334M in total assets and 591 participants in its 2022 DOL Form 5500 filing, ranking in the 97th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.
- 97th percentile by assets (of 139,126 plans)
- #19,613 in Manufacturing (20,602 peers)
Where Baxalta Incorporated and Subsidiaries Pension Plan sits by assets
Baxalta Incorporated and Subsidiaries Pension Plan sits in the top 5% of all filed plans by assets, $334M for 591 participants (~$564,833/participant), down 12.2% in 2022.
- $334M
- total plan assets (2022 EOY)
- 591
- covered participants
- 97th
- percentile by assets (of 139,126 plans)
- $564,833
- avg assets per participant
The plan reported a net loss of $46M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.
Baxalta Incorporated and Subsidiaries Pension Plan vs the 2022 asset distribution
By assets, Baxalta Incorporated and Subsidiaries Pension Plan outranks 97% of the 139,126 plans that filed a Form 5500 for the 2022 plan year, and holds roughly 3.3x the national average plan size of $100M (721 average participants).
Scale-class filing particulars (2022)
| Total Assets (Beginning of Year) | $380M |
|---|---|
| Net Assets (End of Year) | $334M |
| Net Income | -$46M |
| Employer EIN | 134013710 |
| Plan Effective Date | 2015-05-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Takeda Pharmaceuticals North America, Inc)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 2 | 21,188 | $4.9B |
| 2023 | 2 | 22,340 | $5.8B |
| 2024 | 2 | 23,769 | $6.6B |
Nearby Defined Benefit (Pension) Plans in Pennsylvania
Peer Defined Benefit (Pension) plans, same state, same plan type, ranked by total assets.
Baxalta Incorporated and Subsidiaries Pension Plan vs. nearby Defined Benefit (Pension) plans in Pennsylvania, assets vs. participants
- National Elevator Industry Pension Plan $10.4B · 27,097
- Steelworkers Pension Trust $5.9B · 52,395
- The PNC Financial Services Group, Inc. Pension Plan $5.4B · 63,731
- Constellation Retirement Program $5.4B · 5,314
- The Bank of New York Mellon Corporation Pension Plan $5.0B · 8,098
Similar-Sized Defined Benefit (Pension) Plans Nationally
Defined Benefit (Pension) plans in other states closest to Baxalta Incorporated and Subsidiaries Pension Plan by total assets, not by location.
- Suez Water Resources LLC Retirement Plan (NJ) $334M · 540
- Greater Kansas City Laborers Pension Plan (KS) $334M · 878
- Retail Food Employers & Ufcw Local 711 Pension (UT) $333M · 8,484
- Caleres, Inc. Retirement Plan (MO) $333M · 3,222
Frequently Asked Questions
How did Baxalta Incorporated and Subsidiaries Pension Plan assets move in 2022? ▼
How have Takeda Pharmaceuticals North America, Inc plan assets changed over time? ▼
Where does Baxalta Incorporated and Subsidiaries Pension Plan rank by assets among Form 5500 filers? ▼
Which Defined Benefit (Pension) plans are similar in size to Baxalta Incorporated and Subsidiaries Pension Plan? ▼
Next read for Baxalta Incorporated and Subsidiaries Pe…
Scale reading
Ways to act on Baxalta Incorporated and Subsidiaries Pension Plan's numbers.
- By total assets, Baxalta Incorporated and Subsidiaries Pension Plan ranks in the top 5% of all filed plans by assets. See the largest plans
- Compare it side-by-side against 3 similar Defined Benefit (Pension) plans in Pennsylvania. Compare plans
- Takeda Pharmaceuticals North America, Inc's sponsor-wide assets have grown 34.9% since 2022 across 3 plan years on file. More Manufacturing plans